Preemptive Oral Gabapentin 600 mg in Reducing Morphine Requirement After Non Obstetric Lower Abdominal Surgery

Sponsor
Indonesia University (Other)
Overall Status
Completed
CT.gov ID
NCT04434430
Collaborator
(none)
72
1
2
3.6
19.9

Study Details

Study Description

Brief Summary

This study aimed to get the information about the effectiveness of preemptive oral gabapentin 600 mg in reducing morphine requirement after non obstetric lower abdominal surgery

Condition or Disease Intervention/Treatment Phase
Phase 1/Phase 2

Detailed Description

Seventy-two subjects were given informed consent before enrolling the study and randomized into two groups; gabapentin and placebo. Two hours before the incision, patients were given preemptive analgesia, either gabapentin or placebo. Non-invasive blood pressure monitor, electrocardiogram (ECG), and pulse oxymetry were set on the subjects in the operating room. General anesthesia induction was done by fentanyl 2 mcg/kg and propofol 2 mg/kg. Endotracheal tube (ETT) intubation was facilitated with atracurium 0.5 mg/kg as muscle relaxant. Maintenance was done by sevoflurane, oxygen, and compressed air. After surgery, patients were extubated until fully conscious. Patients will be transported to recovery room postoperatively. Besides paracetamol as the postoperative analgesia, we also attached patient controlled analgesia (PCA) system to patients' intravenous line using continuous ambulatory delivery device (CADD) contained morphine 1 mg/ml with settings 1 mg per requirement, interval limit within 5 minutes, maximum dose 6 mg/hour intravenously. Cumulative morphine requirement, mean visual analogue scale, and time interval after surgery to the first administration of morphine will be assessed in this study.

Study Design

Study Type:
Interventional
Actual Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Preemptive Oral Gabapentin 600 mg on Morphine Requirement After Non Obstetric Lower Abdominal Surgery
Actual Study Start Date :
Nov 11, 2019
Actual Primary Completion Date :
Feb 29, 2020
Actual Study Completion Date :
Feb 29, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Gabapentin

Patient will receive preemptive oral gabapentin 600 mg

Drug: Gabapentin
Oral Gabapentin 600 mg

Placebo Comparator: Placebo

Patient will receive oral placebo

Other: Placebo
Oral NaCl 500 mg

Outcome Measures

Primary Outcome Measures

  1. Cumulative morphine requirement within 24 hours after non obstetric lower abdominal surgery [24 hours after surgery]

    Measured by total consumption of morphine on patient controlled analgesia machine

  2. Pain within 24 hours after non obstetric lower abdominal surgerysurgery: visual analogue scale [24 hours after surgery]

    Measured by visual analogue scale The visual analogue scale is a measurement to assess the severity of pain. In this context, the patients will be assessed by letting them point the score on a device based on their pain experiences. The minimum value is 0 and the maximum is 10. The higher the score, the more severe the pain is.

Secondary Outcome Measures

  1. Pain within 2 hours after non obstetric lower abdominal surgerysurgery: visual analogue scale [2 hours after surgery]

    Measured by visual analogue scale The visual analogue scale is a measurement to assess the severity of pain. In this context, the patients will be assessed by letting them point the score on a device based on their pain experiences. The minimum value is 0 and the maximum is 10. The higher the score, the more severe the pain is.

  2. Pain within 6 hours after non obstetric lower abdominal surgerysurgery: visual analogue scale [6 hours after surgery]

    Measured by visual analogue scale The visual analogue scale is a measurement to assess the severity of pain. In this context, the patients will be assessed by letting them point the score on a device based on their pain experiences. The minimum value is 0 and the maximum is 10. The higher the score, the more severe the pain is.

  3. Pain within 12 hours after non obstetric lower abdominal surgerysurgery: visual analogue scale [12 hours after surgery]

    Measured by visual analogue scale The visual analogue scale is a measurement to assess the severity of pain. In this context, the patients will be assessed by letting them point the score on a device based on their pain experiences. The minimum value is 0 and the maximum is 10. The higher the score, the more severe the pain is.

  4. Cumulative morphine requirement within 2 hours after non obstetric lower abdominal surgery [2 hours after surgery]

    Measured by total consumption of morphine on patient controlled analgesia machine

  5. Cumulative morphine requirement within 6 hours after non obstetric lower abdominal surgery [6 hours after surgery]

    Measured by total consumption of morphine on patient controlled analgesia machine

  6. Cumulative morphine requirement within 12 hours after non obstetric lower abdominal surgery [12 hours after surgery]

    Measured by total consumption of morphine on patient controlled analgesia machine

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Male or female

  • Age: 18-65 years old

  • Weigh in range around 20% of the ideal body weight

  • Physical status ASA I-II

  • Scheduled for elective non-obstetric lower abdominal surgery with general anesthesia

  • Duration of surgery less than 4 hours

  • Patients who agreed to participate in this study and sign informed consent

Exclusion criteria:
  • Patients who have history of allergy or hypersensitivity to gabapentin, paracetamol, morphine, or the other opioids

  • Patients who consumed analgesia and NSAID less than 12 hours before surgery

  • Patients who experienced physical trauma less than 4 days before surgery

  • Patients who have contraindications to gabapentin, morphine, and paracetamol

  • Patients who were treated with neuraxial block or peripheral nerve block before and during surgery

  • Patients who have history of diabetes, severe live or renal disease

  • Patients who were treated with antihypertension, sedatives, hypnotics, antidepressants, and the other drugs that have effects on nervous system

  • Patients who have psychiatric disorders

  • Patients who consumed gabapentin before perioperative period

  • Pregnant or breastfeeding patients

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cipto Mangunkusumo Cental National Hospital Jakarta DKI Jakarta Indonesia 10430

Sponsors and Collaborators

  • Indonesia University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andi Ade Wijaya Ramlan, Principal Investigator, Indonesia University
ClinicalTrials.gov Identifier:
NCT04434430
Other Study ID Numbers:
  • IndonesiaUAnes 054
First Posted:
Jun 16, 2020
Last Update Posted:
Sep 13, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andi Ade Wijaya Ramlan, Principal Investigator, Indonesia University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2021